Countering previously held beliefs, researchers at The University of Texas MD Anderson Cancer Center have discovered that inhibiting the immune receptor protein TLR4 may not be a wise treatment strategy in all cancers.
The use of cell therapy after traumatic brain injury (TBI) in children can reduce the amount of therapeutic interventions needed to treat the patient, as well as the amount of time the child spends in neurointensive care, according to research by The University of Texas Health Science Center at Houston (UTHealth) Medical School.
Surgical teams from Houston Methodist Hospital and The University of Texas MD Anderson Cancer Center successfully transplanted, for the first time, a scalp and skull while performing kidney and pancreas transplants.
Surgical teams from Houston Methodist Hospital and The University of Texas MD Anderson Cancer Center successfully transplanted, for the first time, a scalp and skull while performing kidney and pancreas transplants.
Exact Sciences Corp. and The University of Texas MD Anderson Cancer Center today announced an agreement to jointly develop and commercialize blood-based screening and diagnostics tests for the early detection of lung cancer.
Whole Brain Radiation Therapy (WBRT) is associated with significantly worse cognitive function than radiosurgery, and should no longer be used in the adjuvant setting after radiosurgery to treat cancer patients with brain metastases, according to a large study led by a researcher at The University of Texas MD Anderson Cancer Center.
A role for combination therapy using two or more chemotherapy agents at the same time has not been well studied. This week, however, results of a clinical trial presented at the American Society of Clinical Oncology meeting by researchers at The University of Texas MD Anderson Cancer Center may change the perspective on a role for combination chemotherapy in advanced disease.
The world’s leading organization of oncologists will honor Jim Allison, Ph.D., for his pioneering research that led to a new way to treat cancer by unleashing an immune system attack rather than targeting tumors directly. Allison, chair of Immunology at The University of Texas MD Anderson Cancer Center, will receive the Science of Oncology Award at the American Society of Clinical Oncology (ASCO) 2015 Annual Meeting in Chicago on May 31.
A molecule that helps control gene expression may play a role in controlling chemotherapy resistance among patients with the most common form of ovarian cancer.
Men who drink the equivalent caffeine level of two to three cups of coffee a day are less likely to have erectile dysfunction (ED), according to researchers from The University of Texas Health Science Center at Houston (UTHealth).
Researchers from The University of Texas Health Science Center at Houston (UTHealth) School of Public Health have received a $100,000 supplemental grant from the National Institute of Environmental Health Sciences (NIEHS) to establish a Biosafety and Infectious Disease Training Initiative.
Harris Health System has again earned the CEO Cancer Gold Standard™ for its efforts to reduce the risk of cancer for its employees and covered family members. The CEO Cancer Gold Standard™ by the CEO Roundtable on Cancer is given to organizations for their work in promoting healthy lifestyle choices, encouraging early detection through cancer screenings and ensuring access to quality treatment for its employees. Only three other hospital systems in Texas received the accreditation.
Grass plants can bind, uptake and transport infectious prions, according to researchers at The University of Texas Health Science Center at Houston (UTHealth). The research was published online in the latest issue of Cell Reports.
Patients with operable stage I non-small cell lung cancer (NSCLC) could achieve better overall survival rates if treated with Stereotactic Ablative Radiotherapy (SABR) rather than the current standard of care – invasive surgery – according to research from a phase III randomized international study from The University of Texas MD Anderson Cancer Center.
Significant clinical variations exist among patients with the most common type of liver cancer called hepatocellular carcinoma (HCC), depending on the viral cause of the disease –hepatitis B virus (HBV) or hepatitis C virus (HCV). These differences suggest that hepatitis status should be considered when developing treatment plans for newly diagnosed patients, according to researchers at The University of Texas MD Anderson Cancer Center.
As the practice of genetically profiling patient tumors for clinical treatment decision making becomes more commonplace, a recent study from The University of Texas MD Anderson Cancer Center suggests that profiling normal DNA also provides an important opportunity to identify inherited mutations that could be critical for patients and their families.
Blocking FGL2, a protein known to promote cancer, may offer a new strategy for treating brain cancer, according to a study at The University of Texas MD Anderson Cancer Center.
First-grader Destiny Lopez had just sharpened her pencil eager to finish up a writing assignment when she accidently tripped—impaling the pencil through her chest and into her heart. Nearly 15 years later, the now 23-year-old and recent mother, still bears the scar of that near-fatal accident. On May 14, she and caregivers from Harris Health System’s Ben Taub Hospital, as well as first-responders from the Houston Fire Department, will be joined by someone who many consider the unsung hero of the accident—teacher Terry Kirksey, who did not pull out the pencil from Lopez’s chest—giving her a fighting chance to survive the heart injury.
A study revealing fresh insight about chromosome “tails” called telomeres may provide scientists with a new way to look at developing treatments or even preventing a group of blood cell disorders known as myelodysplastic syndromes (MDS).
A new population genetics model developed by researchers at The University of Texas Health Science Center at Houston (UTHealth) School of Public Health could explain why the genetic composition of Finnish people is so different from that of other European populations.
A $1 million grant for stroke research has been awarded from Stryker Neurovascular to Amrou Sarraj, M.D., assistant professor of neurology at The University of Texas Health Science Center at Houston (UTHealth).
The effectiveness of cancer vaccines could be dramatically boosted by first loading the cancer antigens into silicon microparticles, report scientists from Houston Methodist and two other institutions in an upcoming Cell Reports.
Harris Health System’s Lyndon B. Johnson Hospital has been named CNOR Strong by the Competency and Credentialing Institute because of its high number of certified nurses in the operating rooms (CNOR) staff—becoming only the fourth hospital in Houston and 12th in Texas to receive the distinction. To achieve the recognition, hospitals must have more than 50 percent of operating room nurses certified, a rigorous process that involves nurses mastering high standards of perioperative practices.
Researchers at The University of Texas Health Science Center at Houston (UTHealth) are helping to make precision medicine a reality by sequencing entire exomes of people to assess chronic disease risk and drug efficacy. The results of a study on this topic were published in Nature Genetics on Monday.
It’s Your Game (IYG)-Tech, an online-based sexual health education course, promotes more positive attitudes about abstinence, according to researchers at The University of Texas Health Science Center at Houston (UTHealth) School of Public Health.
A nurse-midwife is an option for low-risk expectant mothers at Harris Health System. For sisters, Dominga and Leticia Gomez Lozano, the option became a family affair. Both opted for a certified nurse-wife delivery versus a traditional obstetrical physician birth. They say the experience was life-changing and helped them build on an already strong sibling bond.
President Bill Clinton and General Colin Powell were honored at A Conversation With a Living Legend® in Washington, D.C., April 21 at the John F. Kennedy Center for the Performing Arts.
A http:team of international scientists has identified hundreds of possible new genes in mice that could transform benign skin growths into deadly melanomas.
For some time, cancer scientists have considered the toxin, alpha-amanatin derived from “death cap” mushrooms, as a possible cancer treatment. However, due to its penchant for causing liver toxicity, its potential as an effective therapy has been limited.
Bars and street corners are ideal venues for broad dissemination of HIV prevention information among drug-using male sex workers and other at-risk populations, according to researchers from The University of Texas Health Science Center at Houston (UTHealth).
New findings about regulation of PD-L1, a protein that allows cancer to evade the immune system, has shown therapeutic promise for several cancers, including the most common form of lung cancer.
Successful ovarian cancer treatment often relies on catching it early. A study at The University of Texas MD Anderson Cancer Center may help point to a new method for women at risk.
Researchers pursuing answers to KRAS-mutated lung cancer and ovarian cancer prevention in MD Anderson's Moon Shots Program are chosen for similar roles in SU2C Dream Teams.
Long non-coding RNAs (lncRNA) are unusual in that they don’t encode proteins like normal RNA. Yet they do play a role in regulating cellular functions and interest cancer researchers.
Karina Valencia needed more hope than the physicians and staff could muster shortly after her son’s shooting, the near-death victim of a convenience store robbery. Luckily, she got the hope she needed, and more, from a peer support group set up for family and friends of hospitalized intensive care patients. In particular, was the story shared by group leader Michael Segal, a patient advocate at Harris Health System's Ben Taub Hospital—himself the victim and survivor of a convenience store shooting.
Mutations of the KRAS gene are commonly known to lead to cancer. However, deeper understanding of exactly how they do this continues to be explored by cancer researchers.
Cardiorespiratory fitness is associated with reduced metabolic syndrome risk among smokers, according to researchers from The University of Texas Health Science Center at Houston (UTHealth) School of Public Health.
Cancer scientist James Allison, Ph.D., internationally known for his role in developing a new class of cancer immunotherapies, has been named a recipient of the 2015 Pezcoller Foundation-American Association for Cancer Research (AACR) International Award for Cancer Research. The award will be presented to Allison, at the 2015 AACR Annual Meeting, to be held in Philadelphia, April 18-22.
Researchers at Houston Methodist have invented a new, ex vivo lung cancer model that mimics the process of tumor progression. Tests of the model are published this month in The Annals of Thoracic Surgery (now online).
Derek L. Curtis, new chief nursing officer of Harris Health System’s Lyndon B. Johnson Hospital, wants to enhance the opportunities for nurses and increase their role in patient-centric care where patients and families have a greater say in the hospitalization of loved ones. Additionally, the 21-year nursing professional, wants to encourage nurses to pursue more expert certifications, as well as master’s and doctorate degrees.
The prospect of combining genomically targeted therapies with drugs that free the immune system to attack cancer suggests “we are finally poised to deliver curative therapies to cancer patients,” researchers at The University of Texas MD Anderson Cancer Center note in a review in the April 9 edition of Cell.
Jair Soares, M.D., Ph.D., has been named one of two editors-in-chief for the Journal of Affective Disorders, the official journal of the International Society for Affective Disorders.
The University of Texas MD Anderson Cancer Center and Astellas Pharma Inc. have signed an option agreement to research and develop a new treatment for patients with acute myeloid leukemia (AML).
Spreading the success of cancer immunotherapy beyond those patients currently enjoying powerful, long-term responses to treatment requires greater understanding of the immune response to tumors, two leaders in the field note in a review in the April 3 Science.
The University of Texas MD Anderson Cancer Center and NanoString Technologies, Inc., a provider of life science tools for translational research and molecular diagnostic products, today announced a multi-year collaboration to accelerate the development and adoption of a new type of assay based on NanoString’s nCounter® Analysis System.
Melissa Valerio, Ph.D., M.P.H., has been named regional dean of The University of Texas Health Science Center at Houston (UTHealth) School of Public Health San Antonio Regional Campus.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right